Analysis of the Clinical Effects and Expression Levels of Inflammatory Cytokines in Type B AD Patients after TEVAR Therapy

Abstract

Volume 4 -Issue 2 non-complex stanford type-B AD. Many researchers advocate the use of TEVAR in treatment of acute AD, whereas some scholars believe that drug therapy should be adopted [4][5]. In this study, we investigated the long-term therapeutic effects of the two treatments and their role in suppressing the expression of inflammatory cytokines. Methods PatientsA retrospective analysis was conducted on 60 patients with acute AD admitted to the Cardiac Surgery Department of Xinjiang Uygur Autonomous Region People's Hospital from April 2016 to January 2018. The patients were divided into control group (n=30) and TEVAR group (n=30) according to different treatment methods